Biotech entity
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention CDC, the most common co-covered peer. Nara Organics appears in 1 tracked Biotech story from June 15, 2026. The tracked stories average 2 original sources each.
Last mentioned: Jun 15, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention CDC, the most common co-covered peer. Nara Organics appears in 1 tracked Biotech story from June 15, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Nara Organics. Shared-story counts are live from our verified record — not editorial picks.
A cluster of three infant botulism cases, despite zero positive C. botulinum tests in product lots, has forced Nara Organics to recall all whole milk powdered formula. The incident raises critical quality control and sterility challenges for the organic infant nutrition sector.
Source: newson6.com · cbsnews.com
Nara Organics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
